Jiewen Hou

Ms. Jiewen Hou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
WXWenpin Xia
Wenpin Xia
KZKaiyang Zhang
Kaiyang Zhang
JHJiewen Hou
Jiewen Hou
HFHuaiyu Fu
Huaiyu Fu
MGMingming Gao
Mingming Gao
ZGZhenbing Guo
Zhenbing Guo
Photocatalytic nitrogen fixation under ambient conditions offers a sustainable alternative to the energy-intensive Haber–Bosch process, yet remains limited by the inertness of N≡N bonds and sluggish multi-electron/proton transfer kinetics. Nature’s nitrogenase enzymes, featuring the FeMo cofactor and ATP-driven electron cascades, inspire a new generation of artificial systems capable of mimicking their catalytic precision and selectivity. This review systematically summarizes recent advances in bio-inspired photocatalytic nitrogen reduction, focusing on six key strategies derived from enzymatic mechanisms: Fe–Mo–S active site reconstruction, hierarchical electron relay pathways, ATP-mimicking energy modules, defect-induced microenvironments, interfacial charge modulation, and spatial confinement engineering. While notable progress has been made in enhancing activity and selectivity, challenges remain in dynamic regulation, mechanistic elucidation, and system-level integration. Future efforts should prioritize operando characterization, adaptive interface design, and device-compatible catalyst platforms. By abstracting nature’s catalytic logic into synthetic architectures, biomimetic photocatalysis holds great promise for scalable, green ammonia production aligned with global decarbonization goals.

8 October 2026 in Biology
Verified
Journal Article
Open access
PDF file
HLHao Li
Hao Li
JHJiewen Hou
Jiewen Hou
CHCongzhen He
Congzhen He
CLChangxing Liu
Changxing Liu
BRBowen Ran
Bowen Ran
HHHui-Zi Huang
Hui-Zi Huang
Pancreatic diseases, particularly pancreatic ductal adenocarcinoma (PDAC), remain among the most challenging disorders to diagnose and treat owing to a series of interconnected biological barriers, including dense stromal desmoplasia, profound immunosuppression, hypoxia, therapeutic resistance, and the lack of effective early-detection strategies. Overcoming these barriers requires multifunctional platforms capable of integrating diagnosis, microenvironment regulation, and precision therapy within a single system. Metal–organic frameworks (MOFs), a class of highly tunable porous crystalline materials, have emerged as uniquely suited candidates for this purpose because of their programmable composition, structural versatility, catalytic activity, and capacity for multifunctional integration. Notably, MOFs have evolved from passive drug carriers into active regulators of disease-associated biological processes, enabling enhanced drug delivery, extracellular matrix remodeling, ferroptosis- and cuproptosis-based precision therapy, energy-triggered reactive oxygen species generation, immune microenvironment reprogramming, and imaging-guided theranostics. Beyond pancreatic cancer, emerging evidence further supports their potential applications in pancreatitis management and interventional therapeutic enhancement. In this review, we systematically summarize recent advances in the rational engineering of MOFs for pancreatic diseases, focusing on how material design strategies are leveraged to overcome key pathological barriers and improve therapeutic outcomes. We further discuss current challenges associated with biosafety, biodegradation, large-scale manufacturing, and clinical translation, while highlighting future opportunities for the development of next-generation MOF-based precision nanomedicines. By integrating advances across materials science, nanomedicine, and pancreatic disease biology, this review provides a comprehensive framework for the design and translational development of MOF-enabled diagnostic and therapeutic platforms.

1 July 2026 in Biology
Verified
Journal Article
Open access
PDF file
JHJiewen Hou
Jiewen Hou
XSXinzhe Song
Xinzhe Song
KZKaiyang Zhang
Kaiyang Zhang
XHXuehao Huo
Xuehao Huo
XSXinhao Sun
Xinhao Sun
RHRuodan Han
Ruodan Han
Emerging viral diseases continue to pose major challenges to global health, creating demand for materials that can support pathogen control, diagnosis, and therapy. Owing to their tunable structures and versatile biointerfaces, metal–organic frameworks (MOFs) have attracted increasing attention in anti-pathogen applications. While previous studies have often focused on individual functions such as catalysis, biosensing, or drug delivery, a broader perspective on the functional development of MOF-based systems remains limited. In this Review, we summarize recent advances in MOF-enabled pathogen inactivation, diagnostic biosensing, host-directed intervention, and virus-inspired therapeutic platforms. Emerging opportunities in antiviral drug discovery and artificial intelligence-assisted materials design are also discussed. In addition, key challenges associated with structural stability, biosafety, scalable fabrication, and clinical translation are highlighted. This Review provides an overview of current progress and outlines perspectives for the future development of MOF-based anti-pathogen technologies.